Last ¥288.00 JPY
Change Today -4.00 / -1.37%
Volume 87.6K
2369 On Other Exchanges
As of 2:00 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

medibic group (2369) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/9/13 - ¥541.00
52 Week Low
02/5/14 - ¥242.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDIBIC GROUP (2369)

Related News

No related news articles were found.

medibic group (2369) Related Businessweek News

No Related Businessweek News Found

medibic group (2369) Details

MediBIC Group, Co., Ltd. provides healthcare and drug development services. It provides genetic testing services with diagnostic tools to doctors; GLP-compliant gene profiling services to pharmaceutical companies; and sample banking and management services, as well as focuses on providing health care services to pets. The company is also involved in developing a cell culture system; selling consumables; promoting licensing activities for the pancreatic cancer drug Glufosfamide; research and development of pharmaceuticals and diagnostic agents, etc.; and providing data analysis for preventive health care, as well as clinical trial services to cell therapy. MediBIC Group, Co., Ltd. was founded in 2000 and is headquartered in Tokyo, Japan.

21 Employees
Last Reported Date: 03/27/14
Founded in 2000

medibic group (2369) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medibic group (2369) Key Developments

MediBIC Group, Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended June 30, 2014; Provides Consolidated Earnings Guidance for the Year Ending December 2014

MediBIC Group, Co., Ltd. reported consolidated earnings results for the six months ended June 30, 2014. For the period, the company reported net sales of JPY 81 million compared to JPY 67 million a year ago. Operating loss was JPY 277 million compared to JPY 117 million a year ago. Ordinary loss was JPY 232 million compared to JPY 129 million a year ago. Net loss was JPY 258 million or JPY 9 per share compared to JPY 133 million or JPY 5.14 per share a year ago. For the year ending December 2014, the company expects consolidated net sales of JPY 600 million, operating income of JPY 30 million, ordinary income of JPY 18 million and net income of JPY 5 million or JPY 0.19 per share.

MediBIC Group, Co., Ltd. to Report Q2, 2014 Results on Aug 12, 2014

MediBIC Group, Co., Ltd. announced that they will report Q2, 2014 results on Aug 12, 2014

MediBIC Group, Co., Ltd. to Report Q1, 2014 Final Results on May 13, 2014

MediBIC Group, Co., Ltd. announced that they will report Q1, 2014 final results on May 13, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2369:JP ¥288.00 JPY -4.00

2369 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2369.
View Industry Companies

Industry Analysis


Industry Average

Valuation 2369 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 31.9x
Price/Book 7.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 30.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIBIC GROUP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at